TP53 and cancer: For instance, mitochondrial damage in rat breast cancer cells leads to the accumulation of p53 aggregates that are resistant to lysosome degradation and association with autophagic receptors (NDP52 and TAX1BP1), enhancing cancer cell growth (Biel et al., 2020).